Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.636
-0.314 (-10.63%)
At close: Nov 4, 2024, 4:00 PM
2.800
+0.164 (6.21%)
Pre-market: Nov 5, 2024, 8:38 AM EST
Cyclerion Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 3.01 | -5.26 | -44.08 | -51.65 | -77.8 | -123.01 | |
| Depreciation & Amortization | - | - | 0.07 | 0.47 | 2.3 | 2.7 | |
| Loss (Gain) From Sale of Assets | - | - | - | 6.32 | 0.16 | 0.75 | |
| Asset Writedown & Restructuring Costs | 3.3 | 3.3 | - | - | - | - | |
| Stock-Based Compensation | 0.63 | 1.07 | 6.25 | 9.61 | 14.99 | 19.63 | |
| Other Operating Activities | - | - | - | -2.68 | -4.54 | - | |
| Change in Accounts Receivable | - | 0.1 | 0 | 0.03 | 1.35 | -1.47 | |
| Change in Accounts Payable | -1.21 | -1.77 | 1.14 | 0.39 | -1.1 | -0.25 | |
| Change in Other Net Operating Assets | -1.43 | -2.93 | -4 | 0.99 | -7.84 | -0.57 | |
| Operating Cash Flow | -11.45 | -21.25 | -40.61 | -36.52 | -72.49 | -102.22 | |
| Capital Expenditures | - | - | - | -0.01 | -1.52 | -6.89 | |
| Sale of Property, Plant & Equipment | - | - | - | 1.46 | 1.54 | 0.17 | |
| Other Investing Activities | 10.4 | 10.4 | - | - | - | - | |
| Investing Cash Flow | 10.4 | 10.4 | - | 1.46 | 0.02 | -6.72 | |
| Short-Term Debt Issued | - | - | - | - | 3.51 | - | |
| Total Debt Issued | - | - | - | - | 3.51 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | 3.51 | - | |
| Issuance of Common Stock | 1.95 | 1.98 | 0.03 | 30.79 | 24.58 | 175.51 | |
| Other Financing Activities | -5 | - | - | - | - | 36.06 | |
| Financing Cash Flow | - | 5.02 | 0.03 | 30.79 | 28.09 | 211.57 | |
| Foreign Exchange Rate Adjustments | -0 | 0.01 | 0 | 0 | -0.01 | -0.02 | |
| Net Cash Flow | -1.05 | -5.81 | -40.58 | -4.27 | -44.39 | 102.62 | |
| Free Cash Flow | -11.45 | -21.25 | -40.61 | -36.52 | -74.01 | -109.1 | |
| Free Cash Flow Margin | - | - | -13673.74% | -926.53% | -3223.61% | -2420.75% | |
| Free Cash Flow Per Share | -4.63 | -9.09 | -18.69 | -18.66 | -48.69 | -79.70 | |
| Levered Free Cash Flow | -6.39 | -9.52 | -8.67 | -20.34 | -38.55 | -71.15 | |
| Unlevered Free Cash Flow | -6.39 | -9.52 | -8.67 | -20.33 | -38.55 | -71.15 | |
| Change in Net Working Capital | 2.32 | 4.56 | 3.4 | -3.55 | 2.48 | 8.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.